CKD in China: Evolving Spectrum and Public Health Implications
- PMID: 31492486
- DOI: 10.1053/j.ajkd.2019.05.032
CKD in China: Evolving Spectrum and Public Health Implications
Abstract
Diabetes is the leading cause of kidney failure worldwide, whereas glomerulonephritis has been predominant in developing countries such as China. The prevalence of obesity and diabetes has increased dramatically in developing countries, substantially affecting the patterns of chronic kidney disease (CKD) observed in these regions. Using data from the Hospital Quality Monitoring System to evaluate changes in the spectrum of non-dialysis-dependent CKD in China, we have observed an increase in the percentage of patients with CKD due to diabetes, which has exceeded that of CKD due to glomerulonephritis since 2011, as well as an increase in hypertensive nephropathy and, in some regions, obstructive kidney disease (mostly associated with kidney stones). The growth of noncommunicable diseases under profound societal and environmental changes has shifted the spectrum of CKD in China toward patterns similar to those of developed countries, which will have enormous impacts on the Chinese health care system. There is much to be done regarding public health interventions, including the establishment of a national CKD surveillance system, improvement in the management of diabetes and hypertension, and enhancement of the affordability and accessibility of kidney replacement therapy. Reducing the burden of CKD will require joint efforts from government, the medical community (including practitioners other than nephrologists), and the public.
Keywords: CKD prevalence; China; Chronic kidney disease (CKD); chronic disease surveillance; developing world; diabetes; disease burden; end-stage kidney disease (ESKD); health care costs; hypertension; kidney disease etiology; lifestyle factors; metabolic diseases; modifiable risk factor; non-communicable diseases; obesity; public health; review; urbanization.
Copyright © 2019 National Kidney Foundation, Inc. All rights reserved.
Similar articles
-
Spectrum of chronic kidney disease in China: A national study based on hospitalized patients from 2010 to 2015.Nephrology (Carlton). 2019 Jul;24(7):725-736. doi: 10.1111/nep.13489. Epub 2019 Apr 30. Nephrology (Carlton). 2019. PMID: 30198082
-
Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study.Clin Exp Nephrol. 2018 Apr;22(2):328-336. doi: 10.1007/s10157-017-1451-4. Epub 2017 Jul 27. Clin Exp Nephrol. 2018. PMID: 28752289
-
Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.Am J Kidney Dis. 2018 Nov;72(5):653-661. doi: 10.1053/j.ajkd.2018.02.364. Epub 2018 May 18. Am J Kidney Dis. 2018. PMID: 29784612
-
Prevalence and Disease Burden of Chronic Kidney Disease.Adv Exp Med Biol. 2019;1165:3-15. doi: 10.1007/978-981-13-8871-2_1. Adv Exp Med Biol. 2019. PMID: 31399958 Review.
-
Recent trends in the prevalence of chronic kidney disease: not the same old song.Curr Opin Nephrol Hypertens. 2017 May;26(3):187-196. doi: 10.1097/MNH.0000000000000315. Curr Opin Nephrol Hypertens. 2017. PMID: 28319485 Review.
Cited by
-
The impact of zero markup drug policy on patients' healthcare utilization and expense: An interrupted time series study.Front Med (Lausanne). 2022 Nov 15;9:928690. doi: 10.3389/fmed.2022.928690. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36457568 Free PMC article.
-
Characterization of gut microbiota in patients with stage 3-4 chronic kidney disease: a retrospective cohort study.Int Urol Nephrol. 2024 May;56(5):1751-1762. doi: 10.1007/s11255-023-03893-7. Epub 2023 Dec 12. Int Urol Nephrol. 2024. PMID: 38085410
-
Association between bilirubin and chronic kidney disease in hypertensive patients: The China hypertension registry study.J Clin Hypertens (Greenwich). 2023 Dec;25(12):1185-1192. doi: 10.1111/jch.14727. Epub 2023 Nov 20. J Clin Hypertens (Greenwich). 2023. PMID: 37986685 Free PMC article.
-
ESKD Risk Prediction Model in a Multicenter Chronic Kidney Disease Cohort in China: A Derivation, Validation, and Comparison Study.J Clin Med. 2023 Feb 14;12(4):1504. doi: 10.3390/jcm12041504. J Clin Med. 2023. PMID: 36836039 Free PMC article.
-
Risk factor mining and prediction of urine protein progression in chronic kidney disease: a machine learning- based study.BMC Med Inform Decis Mak. 2023 Aug 31;23(1):173. doi: 10.1186/s12911-023-02269-2. BMC Med Inform Decis Mak. 2023. PMID: 37653403 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical